Summary:
One year study with new class of medication to possibly help improve symptoms of lupus as an add on therapy.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Have diagnosis of lupus for greater than 6 months
•
Be on stable medication for 3 months minimum
•
Not have any other overlapping autoimmune conditions such as rheumatoid arthritis, fibromyalgia, etc.
Qualified Participants May Receive:
Study medication at no cost, reimbursement for time & travel up to $864, free flu & pneumonia vaccinations and free lab testing.